MBX
MBX Biosciences, Inc.
57.90$
-6.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.5% | +17.1% | +31.3% | +19.0% | -22.7% | +32.8% | -1,371.4% | – | +1,630.0% | -166.9% | – | – | |
| – | +70.8% | +59.4% | -43.4% | +29.7% | +24.8% | +23.6% | +5.3% | +15.9% | +18.3% | +106.5% | +10.6% | – | |
| – | -259.4% | – | +365.2% | +37.2% | -122.6% | – | +53.0% | -264.6% | – | -208.0% | – | – | |
| – | +150.0% | +396.4% | +65.6% | -87.4% | +61.4% | -67.4% | +2,256.7% | -43.6% | +98.7% | -44.9% | +106.2% | – | |
| – | +55.6% | – | -151.1% | +1,177.3% | -33.2% | – | +705.5% | -34.4% | -862.0% | -25.3% | – | – | |
| – | -100.0% | +863.2% | -1,062.3% | – | -100.1% | – | +33,050.0% | +14,064.7% | -99.8% | +19,862.3% | -97.3% | – | |
| – | -195.1% | – | -567.6% | – | -169.4% | – | – | +1,756.1% | -180.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.